Labeler
AbbVie Inc. NDC Codes
AbbVie Inc. lists 96 finished drug products in the FDA NDC Directory under NDC labeler codes 0032, 0074.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Synthroid, Skyrizi, Creon, Humira, Lupron Depot-PED, Lupron Depot, Rinvoq, Zemplar, Venclexta, Depakote, Qulipta, Kaletra, Emrelis, Norvir, Mavyret
- Active ingredients
- Levothyroxine sodium, Pancrelipase amylase, Pancrelipase lipase, Pancrelipase protease, Risankizumab, Divalproex sodium, Ritonavir, Upadacitinib, Paricalcitol, Atogepant, Lopinavir, Venetoclax
- NDC labeler codes
- 0032, 0074
- Strengths
- Risankizumab 180 mg/1.2mL; Pancrelipase amylase 30000 [USP'U]/1; Pancrelipase lipase 6000 [USP'U]/1; Pancrelipase protease 19000 [USP'U]/1; Pancrelipase lipase 36000 [USP'U]/1; Pancrelipase amylase 180000 [USP'U]/1; Pancrelipase protease 114000 [USP'U]/1; Pancrelipase amylase 60000 [USP'U]/1; Pancrelipase lipase 12000 [USP'U]/1; Pancrelipase protease 38000 [USP'U]/1; Pancrelipase amylase 15000 [USP'U]/1; Pancrelipase lipase 3000 [USP'U]/1; Pancrelipase protease 9500 [USP'U]/1; Pancrelipase lipase 24000 [USP'U]/1; Pancrelipase protease 76000 [USP'U]/1; Pancrelipase amylase 120000 [USP'U]/1; Divalproex sodium 250 mg/1; Ritonavir 100 mg/1; Risankizumab 150 mg/mL; Divalproex sodium 500 mg/1
- Dosage forms
- Kit, Tablet, Tablet, Film coated, Capsule, Delayed release pellets, Injection, Tablet, Extended release, Injection, Solution, Injection, Powder, Lyophilized, For solution, Tablet, Delayed release, Capsule, Solution, Capsule, Delayed release, Capsule, Liquid filled, Suspension, Liquid, Powder, For solution, Solution/ drops, Pellet, Powder
- Routes
- Oral, Intravenous, Subcutaneous, Respiratory (Inhalation), Ophthalmic, Enteral, Endotracheal
- Drug classes (FDA established)
- l-Thyroxine, Protease Inhibitor, Interleukin-23 Antagonist, Anti-epileptic Agent, Mood Stabilizer, Cytochrome P450 3A Inhibitor, Janus Kinase Inhibitor, Vitamin D Analog, Vitamin D2 Analog, Calcitonin Gene-related Peptide Receptor Antagonist, BCL-2 Inhibitor, Hepatitis C Virus NS3/4A Protease Inhibitor, Hepatitis C Virus NS5A Inhibitor, Gonadotropin Releasing Hormone Receptor Antagonist, Calcineurin Inhibitor Immunosuppressant, General Anesthetic, Monobactam Antibacterial, beta Lactamase Inhibitor, Cholinergic Receptor Agonist, Aromatic Amino Acid
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 179
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Skyrizirisankizumab-rzaa | Risankizumab 55 mg/.37mL | Injection, SolutionSubcutaneous | 0074-4059 | 00074-4059-0100074-4059-71 | — |
| Decnupazpivekimab sunirine-pvzy | Pivekimab sunirine 2 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0074-0282 | 00074-0282-02 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 180 mg/1.2mL | InjectionSubcutaneous | 0074-8300 | 00074-8300-01 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 180 mg/1.2mL | InjectionSubcutaneous | 0074-8350 | 00074-8350-01 | — |
| Emrelistelisotuzumab vedotin | Telisotuzumab vedotin 100 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0074-1055 | 00074-1055-01 | — |
| Emrelistelisotuzumab vedotin | Telisotuzumab vedotin 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0074-1044 | 00074-1044-01 | — |
| Emblaveoaztreonam and avibactam | Aztreonam 127 mg/mL; Avibactam 42.3 mg/mL | Powder, For solutionIntravenous | 0074-3878 | 00074-3878-10 | — |
| Rinvoqupadacitinib | Upadacitinib 1 mg/mL | SolutionOral | 0074-2320 | 00074-2320-0100074-2320-70 | — |
| Skyrizirisankizumab-rzaa | — | Kit | 0074-7040 | 00074-7040-02 | — |
| Skyrizirisankizumab-rzaa | — | Kit | 0074-7042 | 00074-7042-04 | — |
| Creonpancrelipase | Pancrelipase amylase 30000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | 0032-0046 | 00032-0046-3000032-0046-70 | — |
| Creonpancrelipase | Pancrelipase lipase 36000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | 0032-2637 | 00032-2637-0100032-2637-3000032-2637-70 | — |
| Creonpancrelipase | Pancrelipase amylase 60000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | 0032-0047 | 00032-0047-3000032-0047-70 | — |
| Creonpancrelipase | Pancrelipase amylase 15000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed releaseOral | 0032-0045 | 00032-0045-3000032-0045-70 | — |
| Creonpancrelipase | Pancrelipase lipase 24000 [USP'U]/1 + 2 more ingredients | Capsule, Delayed release pelletsOral | 0032-2636 | 00032-2636-0100032-2636-3000032-2636-70 | — |
| Depakotedivalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | 0074-7326 | 00074-7326-13 | — |
| Lupron Depot-PEDleuprolide acetate | — | Kit | 0074-3575 | 00074-3575-01 | — |
| Skyrizirisankizumab-rzaa | — | KitIntravenous | 0074-1065 | 00074-1065-0100074-1065-02 | — |
| Norvirritonavir | Ritonavir 100 mg/1 | Tablet, Film coatedOral | 0074-2340 | 00074-2340-30 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 600 mg/10mL | InjectionIntravenous | 0074-5015 | 00074-5015-0100074-5015-02 | — |
| Skyrizirisankizumab-rzaa | — | KitIntravenous | 0074-1070 | 00074-1070-0100074-1070-02 | — |
| Vyalevfoscarbidopa/foslevodopa | Foscarbidopa 12 mg/mL; Foslevodopa 240 mg/mL | InjectionSubcutaneous | 0074-0501 | 00074-0501-01 | — |
| Vuitypilocarpine hydrochloride | Pilocarpine hydrochloride 12.5 mg/mL | Solution/ dropsOphthalmic | 0074-7098 | 00074-7098-0400074-7098-06 | — |
| Quliptaatogepant | Atogepant 30 mg/1 | TabletOral | 0074-7096 | 00074-7096-0400074-7096-3000074-7096-70 | — |
| Quliptaatogepant | Atogepant 60 mg/1 | TabletOral | 0074-7094 | 00074-7094-0400074-7094-3000074-7094-70 | — |
| Quliptaatogepant | Atogepant 10 mg/1 | TabletOral | 0074-7095 | 00074-7095-30 | — |
| Mavyretglecaprevir and pibrentasvir | Pibrentasvir 20 mg/1; Glecaprevir 50 mg/1 | PelletOral | 0074-2600 | 00074-2600-28 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 150 mg/mL | InjectionSubcutaneous | 0074-2100 | 00074-2100-0100074-2100-70 | — |
| Skyrizirisankizumab-rzaa | Risankizumab 150 mg/mL | InjectionSubcutaneous | 0074-1050 | 00074-1050-0100074-1050-70 | — |
| Oriahnnelagolix and estradiol and norethisterone | — | Kit | 0074-1017 | 00074-1017-1400074-1017-56 | — |
| Kaletralopinavir and ritonavir | Lopinavir 100 mg/1; Ritonavir 25 mg/1 | Tablet, Film coatedOral | 0074-3008 | 00074-3008-60 | — |
| Kaletralopinavir and ritonavir | Lopinavir 200 mg/1; Ritonavir 50 mg/1 | Tablet, Film coatedOral | 0074-4014 | 00074-4014-12 | — |
| Rinvoqupadacitinib | Upadacitinib 15 mg/1 | Tablet, Extended releaseOral | 0074-2306 | 00074-2306-3000074-2306-70 | — |
| Rinvoqupadacitinib | Upadacitinib 45 mg/1 | Tablet, Extended releaseOral | 0074-1043 | 00074-1043-1400074-1043-28 | — |
| Rinvoqupadacitinib | Upadacitinib 30 mg/1 | Tablet, Extended releaseOral | 0074-2310 | 00074-2310-2000074-2310-30 | — |
| Orilissaelagolix | Elagolix sodium 150 mg/1 | Tablet, Film coatedOral | 0074-0038 | 00074-0038-0700074-0038-28 | — |
| Orilissaelagolix | Elagolix sodium 200 mg/1 | Tablet, Film coatedOral | 0074-0039 | 00074-0039-1400074-0039-56 | — |
| Zemplarparicalcitol | Paricalcitol 2 ug/1 | Capsule, Liquid filledOral | 0074-9037 | 00074-9037-30 | — |
| Zemplarparicalcitol | Paricalcitol 1 ug/1 | Capsule, Liquid filledOral | 0074-9036 | 00074-9036-30 | — |
| Mavyretglecaprevir and pibrentasvir | Pibrentasvir 40 mg/1; Glecaprevir 100 mg/1 | Tablet, Film coatedOral | 0074-2625 | 00074-2625-0400074-2625-2800074-2625-56+1 more | — |
| Norvirritonavir | Ritonavir 100 mg/1 | PowderOral | 0074-3399 | 00074-3399-30 | — |
| Humiraadalimumab | — | Kit | 0074-0616 | 00074-0616-0200074-0616-71 | — |
| Humiraadalimumab | — | Kit | 0074-0817 | 00074-0817-02 | — |
| Humiraadalimumab | — | Kit | 0074-0124 | 00074-0124-0100074-0124-0200074-0124-03+2 more | — |
| Humiraadalimumab | — | Kit | 0074-1539 | 00074-1539-03 | — |
| Humiraadalimumab | — | Kit | 0074-2540 | 00074-2540-01 | — |
| Venclextavenetoclax | Venetoclax 100 mg/1 | Tablet, Film coatedOral | 0074-0576 | 00074-0576-1100074-0576-2200074-0576-30 | — |
| Venclextavenetoclax | Venetoclax 10 mg/1 | Tablet, Film coatedOral | 0074-0561 | 00074-0561-1100074-0561-14 | — |
| Venclextavenetoclax | — | Kit | 0074-0579 | 00074-0579-28 | — |
| Venclextavenetoclax | Venetoclax 50 mg/1 | Tablet, Film coatedOral | 0074-0566 | 00074-0566-0700074-0566-11 | — |
AbbVie Inc.: common questions
- What is AbbVie Inc.'s NDC labeler code?
- 0032, 0074. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for AbbVie Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.